543 studies found for:    Open Studies | "Pulmonary Disease, Chronic Obstructive"
Show Display Options
Rank Status Study
21 Recruiting Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Aclidinium Bromide / Formoterol Fumarate;   Drug: Salmeterol / Fluticasone
22 Recruiting Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Fluticasone Furoate/Vilanterol;   Drug: Vilanterol
23 Recruiting A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: fluticasone furoate (FF);   Drug: vilanterol (VI);   Drug: umeclidinium bromide (UMEC)
24 Recruiting A Randomised Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: FF/VI;   Other: Existing Maintenance Therapy
25 Recruiting Study Evaluating the Effect of Fluticasone Furoate/ Vilanterol (FF/VI) Inhalation Powder Compared With Vilanterol (VI) Inhalation Powder on Bone Mineral Density (BMD) in Subjects With Chronic Obstructive Pulmonary Disease (COPD).
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Fluticasone Furoate;   Drug: Vilanterol
26 Recruiting A Double-blind, Placebo-controlled, Crossover Study to Assess the Effect of Aclidinium Bromide 400 μg Bid on COPD Symptoms and Sleep Quality After 3 Weeks of Treatment in Patients With Stable Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Aclidinium bromide;   Drug: Placebo
27 Recruiting eRT Remote Health Monitoring
Conditions: Pulmonary Disease, Chronic Obstructive;   COPD;   Chronic Obstructive Lung Disease;   Bronchitis, Chronic;   Pulmonary Emphysema
Intervention: Behavioral: Remote Health Monitoring
28 Recruiting Nutritional Rehabilitation in Chronic Obstructive Pulmonary Disease (COPD) Patients With Muscle Atrophy
Conditions: Pulmonary Disease, Chronic Obstructive;   Muscular Atrophy
Interventions: Dietary Supplement: Dietary supplementation;   Dietary Supplement: Placebo supplement;   Behavioral: Nutritional counselling;   Behavioral: Feedback on physical activity level
29 Recruiting Muscle Metabolism and Oxygenation During Localized Fatigue-exercise in COPD
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Other: Fatiguing exercise
30 Recruiting T Lymphocyte Cells in Individuals Experiencing an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Disease, Chronic Obstructive;   Lung Diseases, Obstructive
Intervention:
31 Recruiting Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension: Prevalence and Quality of Life
Conditions: Hypertension, Pulmonary;   Pulmonary Disease, Chronic Obstructive
Intervention:
32 Recruiting Feasibility of Inspiratory Muscle Training in People With COPD Who Decline Pulmonary Rehabilitation
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Other: Inspiratory Muscle training
33 Not yet recruiting A Randomized Comparative Effectiveness Research Trial of Three Treatments for COPD Patients
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Salbutamol (Ventolin®);   Drug: Formoterol (Oxis Turbuhaler®);   Drug: Salmeterol / fluticasone (Seretide®);   Drug: Bufei granule;   Drug: Bufeijianpi granule;   Drug: Bufeiyishen granule;   Drug: Yiqizishen granule;   Drug: conventional medicine + TCM
34 Recruiting Study to Evaluate Efficacy and Safety of Mepolizumab for Frequently Exacerbating Chronic Obstructive Pulmonary Disease (COPD) Patients
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Mepolizumab;   Drug: Placebo
35 Recruiting Efficacy and Safety of Mepolizumab as an Add-on Treatment in Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Mepolizumab;   Drug: Placebo
36 Recruiting Endothelial Dysfunction and Chronic Obstructive Pulmonary Disease
Conditions: Chronic Obstructive Pulmonary Disease;   Endothelial Dysfunction
Intervention:
37 Unknown  Outpatient Management of Patients With Exacerbation of Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Procedure: Patient education and disease management
38 Recruiting Role of Fibrocytes in the Bronchial Remodelling of Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Intervention:
39 Not yet recruiting Treatment in Patients Hospitalized With Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Intervention:
40 Recruiting Impact of Early Respiratory Rehabilitation in the Exacerbations of Re-admitted COPD Patients
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Procedure: Early Respiratory Rehabilitation Program;   Procedure: Conventional Respiratory Rehabilitation Program

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years